Why Avoid Black Pepper in Turmeric?

When buyers ask us why some people recommend avoiding black pepper in turmeric, they usually have the same concern: has something changed about a combination the supplement industry has used for years?Our answer is that the combination still has a research basis, but it needs context. Piperine-the main pungent compound in black pepper-can increase exposure to curcumin. It can also affect exposure to certain medicines. Separately, turmeric supplements have been linked to rare liver injuries, including cases involving products containing piperine.

Those findings justify careful assessment; they do not establish that piperine alone causes the injuries or that everyone should avoid the two spices in food. [1–4] We therefore distinguish normal culinary use from concentrated supplementation. For a brand or manufacturer, we then ask a practical question: does this formula have a sound reason to include piperine, and can we support that choice with the right evidence?

Does the Warning Apply to Your Product?

Are we discussing seasoning or a concentrated extract?

We start here because "turmeric with black pepper" can describe very different products.

A meal seasoned with both spices is not equivalent to a capsule containing concentrated curcuminoids and a standardized piperine extract. Even two supplements labeled "turmeric 500 mg" may differ substantially if one contains turmeric powder and the other contains a concentrated extract.

Australia's Therapeutic Goods Administration, or TGA, identifies a rare risk of liver injury from turmeric or curcumin in medicinal dosage forms. Its advisory distinguishes this risk from typical dietary consumption of turmeric. It also notes that higher doses or increased-bioavailability products may carry greater risk, although available information cannot conclusively identify which products are highest risk. [1]

Before discussing a commercial ingredient, we clarify the extract weight, active content, serving size, and intended daily intake. Otherwise, we may be comparing products that share a name but deliver very different exposures.

What concern prompted the question?

We separate three issues: medication interactions, digestive tolerance, and turmeric-associated liver injury.Each calls for a different response. If the concern is medication use, a contaminant report cannot resolve it. If the concern is beverage tolerance, an absorption study cannot establish how the finished drink will perform.This helps us avoid a common purchasing mistake: requesting more documents without first identifying what those documents need to prove.

Does Your Formula Need Piperine?

What does the familiar "2,000%" figure mean?

We understand why this number appears so often in turmeric marketing. In a 1998 study, Shoba and colleagues investigated curcumin with and without piperine. In the human experiment, 2 grams of curcumin combined with 20 milligrams of piperine produced a reported 2,000% increase in bioavailability. Higher serum concentrations were observed during the early measurement period, approximately 15 minutes to one hour after administration. [2] We use this finding to explain the rationale for the combination. We do not use it as a guaranteed result for every commercial product.

For us, the important distinction is between more exposure and a better finished product. The first is a research measurement. The second requires evidence relevant to the formula, intended use, and users.

Does the curcumin ingredient already use an absorption system?

Before selecting piperine, we review the curcumin ingredient itself.NCCIH notes that curcumin products vary in composition and may contain other ingredients intended to improve bioavailability. These differences make research difficult to compare. It also reports liver damage in some users of increased-bioavailability formulations. [3]

If a customer already uses a curcumin ingredient with a studied delivery system, we ask what additional piperine is expected to accomplish. Adding another absorption approach should have a reason beyond matching a competitor's label.We also keep branded-ingredient research in its proper scope. A study involving a named ingredient or specific formula does not automatically establish equivalent performance for another material with the same declared percentage.

When Is Greater Caution Justified?

Could piperine change exposure to medication?

We take this concern seriously because human research provides a concrete example.Bedada and Boga studied 12 healthy volunteers who received a single 120 mg dose of fexofenadine, an antihistamine, before and after 20 mg piperine daily for 10 days. The researchers reported these changes: [4]

From those values, we calculate approximately 89% higher peak concentration and 68% higher overall exposure. AUC describes exposure over time. [4] We would not apply these percentages to other drugs, lower piperine doses, or every finished supplement. The study was small and investigated a specific treatment schedule. Nevertheless, it demonstrates why an ingredient used to change absorption deserves attention when medication is involved.

Laboratory experiments also showed inhibition of P-glycoprotein and CYP3A4, which participate in transporting or metabolizing certain drugs. We treat those findings as supporting evidence for interaction assessment, rather than a prediction of harm in every user. [5] pubmed.ncbi.nlm.nih.gov

For consumers taking medication, we recommend consulting a pharmacist or clinician before using concentrated piperine supplements. For brands, we consider the intended population before settling the formula.

Do liver-injury reports prove that piperine is responsible?

We cannot draw that conclusion from the available cases.A Drug-Induced Liver Injury Network publication described 10 turmeric-associated liver-injury cases. Five patients were hospitalized, and one died of acute liver failure. Researchers analyzed seven available products: all contained turmeric, and three also contained piperine. Seven patients carried the HLA-B*35:01 allele, suggesting individual susceptibility may be relevant. [6] 

We regard these findings as important. But the study did not compare otherwise identical formulas with and without piperine. It cannot establish the population incidence or isolate piperine's contribution. The authors called for further investigation of possible combined effects. [6]Our conclusion is that removing piperine does not complete a turmeric product's safety assessment. Equally, the ingredients' history of use does not justify dismissing adverse-event reports.

We follow TGA's precaution concerning the relevant turmeric or curcumin medicinal products for people with existing or previous liver problems. [1] If someone develops jaundice, dark urine, unusual fatigue, nausea, or poor appetite while taking a turmeric supplement, we advise stopping use and seeking medical attention promptly, consistent with NCCIH guidance. [3]

Should You Keep Piperine in the Development Plan?

We bring the evidence back to the project rather than asking buyers to choose between "always include it" and "always avoid it."

We do not infer a universal safe intake from the studies above. A research dose is not automatically a recommended daily amount.We also would not describe a lower-percentage extract as inherently safer. If two specifications deliver the same piperine quantity, the percentage alone does not establish a safety advantage.Once the team has a supported reason to proceed, we can make the raw-material comparison more precise.

Which Piperine Specification Fits Your Product?

How much actual piperine will the extract provide?

At Botanical Cube, we supply black pepper extract options including 4% water-soluble, 10%, 50%, 95%, and 98% piperine specifications.

Our first calculation separates extract weight from active content:

Piperine quantity = ingredient quantity × piperine content

If a development team has independently selected a target of 5 mg piperine per serving, the theoretical ingredient quantities are:

We use 5 mg only to explain the calculation. It is not a recommended dose or safety threshold.

This example makes price comparisons more useful. We can compare the ingredient cost for the intended batch, rather than comparing prices per kilogram across different concentrations.It also shows why the highest percentage does not settle every decision. In this example, 95% and 98% materials differ by approximately 0.16 mg of ingredient per serving. Assay reliability, composition, handling, and consistency still deserve review.

Before production calculations, we confirm the reporting basis, specification tolerance, and manufacturing requirements.

Which options should you sample first?

For capsules or tablets where formulation space is limited, we can discuss high-content specifications for evaluation. Small additions require appropriate weighing and blending controls, so we include processing needs in the discussion.For beverage projects, we can review our 4% water-soluble grade as a candidate. We first confirm composition and agree on the conditions that matter to the customer.We do not assume the same grade suits a capsule, an acidic shot, and a powdered drink mix simply because each formula contains turmeric.

What Evidence Should Support Your Choice?

What should a useful product dossier contain?

We want the documents to answer the customer's actual acceptance requirements. Our review starts with:

Depending on the application and destination, we discuss requirements for heavy metals, pesticide residues, residual solvents, ETO-related testing, and microbiology.For third-party testing, we check the sample, batch number, methods, date, and scope. We distinguish a historical reference report from a report supporting a current batch.We can discuss available Botanical Cube documentation and additional testing needs before the customer commits to a sample or order. We confirm the actual scope rather than treating every report as interchangeable.

How should we evaluate water-soluble performance?

For a water-soluble grade, we agree on concentration, temperature, pH, mixing, and observation time. We also clarify whether the observed behavior is dissolution or dispersion.Then we test it in the intended formula. A clear-water demonstration does not establish stability after adding curcumin, acids, flavors, or other ingredients.

We keep three questions separate:

does the ingredient behave as required in water, does it remain acceptable in the finished product, and what evidence supports human exposure? One result cannot answer all three.

What counts as a successful sample?

We define this before testing.For dry products, the criteria may include handling, blend uniformity, and finished-product assay. For liquids, we may evaluate appearance, sediment, flavor, content, and stability under the planned conditions.

Once the sample passes, we record the approved specification and acceptance criteria for the trial order. That gives purchasing, quality, and production teams the same reference.We also remain clear about the limits: a compliant COA supports raw-material quality. It does not prove that the complete supplement has no interaction risk or will suit every individual.

Piperine Supply & Custom Orders

At Botanical Cube, we supply black pepper extracts standardized to 10%, 50%, 95% and 98% piperine, plus a 4% water-soluble grade. Samples, product specifications, and available COA and HPLC data can be requested for your team's review.Tell us whether you are making capsules, tablets, or drinks, along with your required specification, order quantity, and destination country. If you have not chosen a grade, we can discuss the options for testing in your formula.We also handle custom and OEM/private-label enquiries. Send us your formulation, powder specifications, or packaging requirements, and we will confirm what we can offer, pricing, and lead time.

References

[1] Therapeutic Goods Administration. Medicines containing turmeric or curcumin-risk of liver injury. Safety advisory. August 15, 2023. Read the advisory.

[2] Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Medica. 1998;64(4):353–356. doi:10.1055/s-2006-957450.

[3] National Center for Complementary and Integrative Health. Turmeric: Usefulness and Safety. Read the resource.

[4] Bedada SK, Boga PK. The influence of piperine on the pharmacokinetics of fexofenadine, a P-glycoprotein substrate, in healthy volunteers. European Journal of Clinical Pharmacology. 2017;73(3):343–349. doi:10.1007/s00228-016-2173-3.

[5] Bhardwaj RK, Glaeser H, Becquemont L, Klotz U, Gupta SK, Fromm MF. Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4. Journal of Pharmacology and Experimental Therapeutics. 2002;302(2):645–650. doi:10.1124/jpet.102.034728.

[6] Halegoua-DeMarzio D, et al. Liver Injury Associated with Turmeric-A Growing Problem: Ten Cases from the Drug-Induced Liver Injury Network [DILIN]. The American Journal of Medicine. 2023;136(2):200–206. doi:10.1016/j.amjmed.2022.09.026.